Substituted Aurones for Multi-Target Therapeutic Activity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for trypanosomatid, fungal, and inflammatory diseases lack effective compounds with broad-spectrum biological activity, particularly in addressing trypanosomal, fungal, and immunomodulatory needs.

Innovation Solution

Development of substituted aurones with specific structures, such as those depicted in Formulas I and II, which exhibit anti-trypanosomal, anti-fungal, and immunomodulatory activities, synthesized through covalent linking of coumaranones and aldehydes, and formulated into pharmaceutical compositions for systemic or localized administration.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current treatments are used for trypanosomatid, fungal, and inflammatory diseases, then disease treatment is provided, but broad-spectrum biological activity and efficacy are insufficient

Engineering Contradiction:
Improvebiological activityVSAvoidbroad-spectrum activity
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The aurone compound structure is designed to perform multiple biological functions simultaneously. The core aurone scaffold with specific substituents (Y=O, N, or S; Z=substituted aryl group; R2=various groups; a=0-4) enables the compound to exhibit anti-trypanosomal, anti-fungal, and immunomodulatory activities, allowing one compound to address multiple disease types that previously required different treatments

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention uses a composite molecular structure combining the aurone core with diverse substituent groups. This composite structure integrates multiple functional moieties that confer different biological activities, creating a multi-functional therapeutic agent that can target parasites, fungi, and inflammatory pathways simultaneously

Inventive Principle:
Principle #40Composite materials

2Reliability

If substituted aurones are synthesized and administered, then multi-faceted therapeutic effects are achieved, but toxicity concerns arise

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidtoxicity
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention optimizes the physical and chemical parameters of the aurone compound by varying substituents (Y, Z, R2, a) to achieve the desired therapeutic window. By adjusting molecular weight, lipophilicity, and functional groups, the compound maintains high efficacy against trypanosomatids, fungi, and inflammatory conditions while minimizing toxicity to mammalian cells

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The substituted aurones demonstrate significant parasite inhibition, antifungal activity, and immunomodulatory effects, offering a multi-faceted approach to treating trypanosomatid infections, fungal diseases, and inflammatory conditions with potential for low toxicity and high efficacy.

Implementation Method 1

covalently linking a coumaranone and an aldehyde, such as a benzaldehyde or a furaldehyde

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Data Source

PatentUS11286245B2Therapeutic aurones
Publication Date: 2022.03.29 MIDDLE TENNESSEE STATE UNIVERSITY
  • US11286245B2 patent drawing
  • US11286245B2 patent drawing
  • US11286245B2 patent drawing

AI summary

Substituted aurones were found to have antitrypanosomal, antifungal and immunomodulatory activity. The invention provides novel aurone compounds, pharmaceutical compositions, and methods encompassing medical and veterinary applications.